effects of atorvastatin on negative sign in chronic schizophrenia: a double blind clinical trial

Authors

mehdi sayyah faculty member of jundishapur university

hatam boostani faculty member of psychiatry group, psychiatrist, ahvaz jundishapur university of medical sciences, ahvaz, iran

mitra ashrafpoori resident of psychiatry, ahvaz jundishapur university of medical sciences, ahvaz, iran

siroos pakseresht faculty member of medicinal plants research center, psychiatrist, ahvaz jundishapur university of medical sciences, ahvaz, iran

abstract

the aim of this study was to evaluate the effects of atorvastatin on negative symptoms in patients with chronic schizophrenia. the study was a prospective, double-blind, 6-week trial. forty patients participated in the study; 19 patients were assigned to the atorvastatin group as well as 21 patients to the placebo group. for assessing negative signs, we used scale for the assessment of negative symptoms (sans) in weeks 1st, 3nd, 4th, and 6th. moreover, patients were randomly assigned to treatment groups with risperidone (6 mg/day) plus 20 mg atorvastatin or with risperidone (6 mg/day) plus placebo. mean scores of scale for the assessment of negative symptoms (sans) decreased during the treatment but there was no significant difference between the mean scores of two groups. the result of this trial suggested that atorvastatin can be effective in reducing negative sign in schizophrenia although further studies seem to be needed.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Effects of Atorvastatin on negative sign in chronic schizophrenia: A double blind clinical trial

The aim of this study was to evaluate the effects of Atorvastatin on negative symptoms in patients with chronic schizophrenia. The study was a prospective, double-blind, 6-week trial. Forty patients participated in the study; 19 patients were assigned to the Atorvastatin group as well as 21 patients to the placebo group. For assessing negative signs, we used Scale for the Assessment of Negative...

full text

Effects of Atorvastatin on negative sign in chronic schizophrenia: A double blind clinical trial

The aim of this study was to evaluate the effects of Atorvastatin on negative symptoms in patients with chronic schizophrenia. The study was a prospective, double-blind, 6-week trial. Forty patients participated in the study; 19 patients were assigned to the Atorvastatin group as well as 21 patients to the placebo group. For assessing negative signs, we used Scale for the Assessment of Negative...

full text

Effects of Atorvastatin on Negative Sign in Chronic Schizophrenia: a Double Blind Clinical Trial

The aim of this study was to evaluate the effects of Atorvastatin on negative symptoms in patients with chronic schizophrenia. The study was a prospective, double-blind, 6-week trial. Forty patients participated in the study; 19 patients were assigned to the Atorvastatin group as well as 21 patients to the placebo group. For assessing negative signs, we used Scale for the Assessment of Negative...

full text

Effects of Bromocriptine on Negative Symptoms of Schizophrenia: A Double Blind Clinical Trial

Negative symptoms are still a major obstacle in the recovery of schizophrenic patients. Many attempts to develop novel drugs affecting negative symptoms of schizophrenia have yielded insignificant results. This study evaluates the effects of bromocriptine, a dopamine agonist, on negative symptoms of schizophrenia utilizing a placebo-controlled crossover double-blind clinical trial. Methodology:...

full text

Treatment-Responsiveness of Negative Symptoms in Schizophrenia: A double-blind placebo-control clinical trial

Background: The negative symptoms of schizophrenia remain a major clinical challenge. Nortriptyline is a serotonin and noradrenalin reuptake inhibitor and belongs to secondary amine tricycles. The aim of this study is to evaluate the effect of nortriptyline on the negative symptoms of schizophrenia. Methods: This study is a six-week randomized placebo-control trial of nortriptyline or placebo a...

full text

Evaluating the Efficacy of Vitamin D Add-on Therapy on Treatment of Positive, Negative and Cognitive Symptoms in Patients with Chronic Schizophrenia; A Double Blind Clinical Trial

Background: Vitamin D can be effective in treating some symptoms of schizophrenia, and with better control of vitamin D levels and supplementation, there is a potential for reducing this disease. But due to small number of studies, more studies are needed in this area. The aim of this study was to determine the efficacy of vitamin D as an adjunct to the positive, negative, and cognitive symptom...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of pharmaceutical research

جلد ۱۴، شماره ۴، صفحات ۱۲۶۹-۱۲۷۴

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023